[Lectures] Morphogenetically active amorphous polyphosphate nanoparticles: a foundational breakthrough invention for personalized and regenerative medicine & Can microfluidic solve the problems in biomanufacturing-based nanotherapeutics


Time: Jan.6, Monday, 9:30-11:30
Venue: Meeting Room on the 1st floor, Building B2, University Town Campus

Title 1Morphogenetically active amorphous polyphosphate nanoparticles: a foundational breakthrough invention for personalized and regenerative medicine
Speaker: Prof. Werner E. G. Müller, Johannes Gutenberg University Mainz

Prof. Werner E. G. Müller is the Senator and the Academician of the Erfurt Academy of Sciences (Germany), as well as the Academician of the Croatian Academy of molecular biology, (bio)chemistry and tissue engineering. Based on his research achievements, he has been awarded with one ERC Advanced Investigator Grant and three ERC Proof of Concept Grants in the field of enzyme-based biomineralization and regenerative medicine. He was also a recipient of a grant in the frame of the International Human Frontier Science Program. His work had been recognized by more than 20 national and international scientific awards, including the highest award from Germany “German Federal Cross Medal; 1st class” and the “Friendship Award” from China. He has more than 1,200 publications (Hirsch-index: 84; ISI Web of Science), 21 granted patents and 15 patent applications [DEPATISnet – Data base: 226 hits].

Title 2: Can microfluidic solve the problems in biomanufacturing-based nanotherapeutics
Speaker: Prof. Kam W. Leong, Columbia University

Kam W. Leong is the Samuel Y. Sheng Professor of Biomedical Engineering at Columbia University. He received his PhD in Chemical Engineering from the University of Pennsylvania. After serving as a faculty in the Department of Biomedical Engineering at The Johns Hopkins School of Medicine for almost 20 years, he moved to Duke University in 2006 to study the interactions of cells with nanostructures for therapeutic applications. After moving to Columbia University in September 2014, he continues to work on nanoparticle-mediated nonviral gene delivery and immunotherapy. He also works on the application of nanostructured biomaterials for regenerative medicine, particularly on understanding cell-topography interactions and on the application of nonviral vectors for direct cellular reprogramming and genome editing. He has published ~330 peer-reviewed research manus with >39,000 citations, an h-index of 103, and holds more than 50 issued patents. His work has been recognized by a Young Investigator Research Achievement Award of the Controlled Release Society, Distinguished Scientist Award of the International Journal of Nanomedicine, Clemson Award for Applied Research of the Society for Biomaterials, and Life Time Achievement Award of the Chinese American Society of Nanomedicine and Nanotechnology. He is the Editor-in-Chief of Biomaterials, a member of the USA National Academy of Inventors, and a member of the USA National Academy of Engineering.

Announced by the School of Materials Science and Engineering